Newton C R, Krishna S
Neurosciences Unit, Institute of Child Health, Wolfson Centre, London, UK.
Pharmacol Ther. 1998 Jul;79(1):1-53. doi: 10.1016/s0163-7258(98)00008-4.
Severe falciparum malaria is one of the most lethal parasitic infections in the world and is responsible for more than one million deaths in African children per year. Changes to management over the last 40 years have not improved survival. A reduction in the mortality and morbidity may only come about by a better understanding of the pathophysiological processes that are responsible for severe disease and that determine the outcome before antimalarials have had time to work. This review discusses potential adjunctive therapies for severe malaria that are under development following such detailed clinical and pathophysiological studies.
重症恶性疟是世界上最致命的寄生虫感染之一,每年导致非洲超过100万儿童死亡。过去40年管理方式的改变并未提高生存率。只有更好地了解导致重症疾病并在抗疟药发挥作用之前决定预后的病理生理过程,才可能降低死亡率和发病率。本综述讨论了在进行此类详细临床和病理生理研究后正在研发的重症疟疾潜在辅助疗法。